首页> 美国卫生研究院文献>The FASEB Journal >Recommendations concerning the new U.S. National Institutes of Health initiative to balance the sex of cells and animals in preclinical research
【2h】

Recommendations concerning the new U.S. National Institutes of Health initiative to balance the sex of cells and animals in preclinical research

机译:有关新的美国国立卫生研究院倡议的建议以在临床前研究中平衡细胞和动物的性别

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The U.S. National Institutes of Health (NIH) announced last May that steps will be taken to address the over-reliance on male cells and animals in preclinical research. To further address this announcement, in September 2014, scientists with varying perspectives came together at Georgetown University to discuss the following questions. (1) What metrics should the NIH use to assess tangible progress on policy changes designed to address the over-reliance on male cells and animals in preclinical research? (2) How effective can education be in reducing the over-reliance on male cells and animals in preclinical research and what educational initiatives sponsored by the NIH would most likely effect change? (3) What criteria should the NIH use to determine rigorously defined exceptions to the future proposal requirement of a balance of male and female cells and animals in preclinical studies? (4) What additional strategies in addition to proposal requirements should NIH use to reduce the overreliance of male cells and animals in preclinical research? The resulting consensus presented herein includes input from researchers not only from diverse disciplines of basic and translational science including biology, cell and molecular biology, biochemistry, physiology, pharmacology, neuroscience, cardiology, endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized experts in publishing, industry, advocacy, science policy, clinical medicine, and population health. We offer our recommendations to aid the NIH as it selects, implements, monitors, and optimizes strategies to correct the over-reliance on male cells and animals in preclinical research.—Sandberg, K., Umans, J. G., Georgetown Consensus Conference Work Group. Recommendations concerning the new U.S. National Institutes of Health initiative to balance the sex of cells and animals in preclinical research.
机译:美国国立卫生研究院(NIH)去年5月宣布,将采取措施解决临床前研究中对雄性细胞和动物过度依赖的问题。为了进一步解决这一问题,2014年9月,观点各异的科学家齐聚乔治敦大学,讨论了以下问题。 (1)美国国立卫生研究院应使用哪些指标来评估旨在解决临床前研究中过度依赖雄性细胞和动物的政策变化的切实进展? (2)在减少临床前研究中对雄性细胞和动物的过度依赖方面,教育如何有效?由美国国立卫生研究院(NIH)赞助的哪些教育计划最有可能产生影响? (3)在临床前研究中,美国国立卫生研究院应使用什么标准来确定严格定义的例外,以应对将来提议的平衡雄性和雌性细胞与动物的要求? (4)NIH除了提议要求外,还应使用哪些其他策略来减少临床前研究中雄性细胞和动物的过度依赖?本文提出的最终共识包括研究人员的意见,这些研究人员不仅来自基础和转化科学的不同学科,包括生物学,细胞和分子生物学,生物化学,生理学,药理学,神经科学,心脏病学,内分泌学,肾病学,精神病学以及妇产科。来自出版,行业,宣传,科学政策,临床医学和人口健康方面的知名专家。我们提供建议,以帮助NIH在临床前研究中选择,实施,监控和优化策略以纠正对雄性细胞和动物的过度依赖。—Sandberg,K.,Umans,J.G.,Georgetown Consensus Conference Work Group。有关新的美国国立卫生研究院倡议的建议,以在临床前研究中平衡细胞和动物的性别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号